Valentina I. Vinogradova

Valentina I. Vinogradova

Auto-generated profile, based on publicly available information

Valentina I. Vinogradova

Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, M. Ulugbek Str 77, Tashkent 100170, Uzbekistan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
AAAzizbek A. Azamatov
Azizbek A. Azamatov
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
VVValentina I. Vinogradova
Valentina I. Vinogradova
FTFiruza Tursunkhodzhaeva
Firuza Tursunkhodzhaeva
RKRoaa Matouq Khinkar
Roaa Matouq Khinkar
NMNilufar Mamadalieva
Nilufar Mamadalieva
Isoquinoline alkaloids constitute one of the most common classes of alkaloids that have shown a pronounced role in curing various diseases. Finding ways to reduce the toxicity of these molecules and to increase their therapeutic margin is an urgent matter. Here, a one-step method for the synthesis of a series of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines was performed in 85–98% yield by the Pictet–Spengler reaction. This was accomplished using the reaction between 3,4-dimethoxyphenylethylamine and substituted benzaldehydes boiling in trifluoroacetic acid. Furthermore, 1-(3′-amino-, 4′-aminophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines were obtained in 94% and 97% yield by reduction in 1-(3′-nitro-, 4′-nitrophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines with SnCl2 × 2H2O. The structures of the substances obtained were confirmed by infrared (IR) and nuclear magnetic resonance (1H and 13C NMR) spectra. ADMET/TOPKAT in silico study concluded that the synthesized compounds exhibited acceptable pharmacodynamic and pharmacokinetic properties without carcinogenic or mutagenic potential but with variable hepatotoxicity. The acute toxicity and structure–toxicity relationship (STR) in the series of 20 derivatives of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines (3a–r, 4a, b) was studied via determination of acute toxicity and resorptive action in white mice employing intragastric step-by-step administration. The first compound, 1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (3a), showed the highest toxicity with LD50 of 280 mg/kg in contrast to 1-(3′-bromo -4′-hydroxyphenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (3e) which proved to be the safest of the compounds studied. Its toxicity was 13.75 times lower than that of the parent compound 3a. All compounds investigated showed high local anesthetic activity on rabbit eyes in the concentrations studied. Only 3r, 3n, and 4a caused eye irritation and redness. All investigated derivatives (except 4b) in 1% concentration were more active than lidocaine, providing longer duration of complete anesthesia. Therefore, based on the obtained results of in silico tests, local anesthesia, and acute toxicity, a conclusion can be drawn that the experimental compounds need further extensive future investigations and possible modifications so that they can act as promising drug candidates.

18 December 2020 in Proceedings
Verified
Conference Paper
Open access
PDF file
ATAkmaljon Tojiboev
Akmaljon Tojiboev
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
Ulli EnglertUlli Englert
Ulli Englert
RWRuimin Wang
Ruimin Wang
IKIrmgard Kalf
Irmgard Kalf
TBTashkhodjaev Bakhodir
Tashkhodjaev Bakhodir
The crystal structures of 4-(3,4-dimethoxyphenylethylamino)-methylidene-2,3,4,10-tetrahydro-1H-pyrido[2,1-b]-quinazolin-10-one (1) and 4-(3,4-methylene-dioxyphenylethylamino)-methylidene-2,3,4,10-tetrahydro-1H-pyrido[2,1-b]-quina-zolin-10-one hydrochloride (2) were studied by single crystal X-ray diffraction. Their molecular and crystal structures are described in the context of intra- and inter-molecular interactions and of stereoisomerism. The crystallographic study established mixed E, Z configuration about the C4=C12 bond for (1) and E configuration about the C4=C12 bond for (2). For molecular crystals, Hirshfeld surface analyses may provide insight into intermolecular interactions, and energy framework analyses allow one to quantify different contributions to the overall energy. These analyses were performed to pinpoint intermolecular interactions in (1) and (2). According to our results, the molecules are associated with intra- and intermolecular hydrogen bonds, C-H···π and π-stacking interactions. The three-dimensional Hirshfeld surface analyses and two-dimensional fingerprint plots revealed that the structures are dominated by H···H, H···C/C···H and H···O/O···H contacts. The intermolecular energy analysis confirmed a significant contribution of dispersion to the stabilization of molecular packings in (1) and (2).

1 January 2021 in Acta Crystallographica Section E Crystallographic Communications
Verified
Journal Article
Open access
PDF file
ATAkmaljon Tojiboev
Akmaljon Tojiboev
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
VVValentina Vinogradova
Valentina Vinogradova
Ulli EnglertUlli Englert
Ulli Englert
RWRuimin Wang
Ruimin Wang
At 100 K, the title compound, C13H12N2O2, crystallizes in the orthorhombic space group Pna21 with two very similar molecules in the asymmetric unit. An intramolecular N—H...O hydrogen bond leads to an S(6) graph-set motif in each of the molecules. Intermolecular π–π stacking and C=O...π interactions involving the aldehyde O atoms link molecules into stacks parallel to [100]. A Hirshfeld surface analysis indicates that the most important contributions to the crystal packing stem from H...H (49.4%) and H...O/O...H (21.5%) interactions. Energy framework calculations reveal a significant contribution of dispersion energy. The crystal studied was refined as a two-component inversion twin.

9 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AAAzizbek A. Azamatov
Azizbek A. Azamatov
NMNilufar Mamadalieva
Nilufar Mamadalieva
AMAsmaa A. Mandour
Asmaa A. Mandour
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
UAUrkhiya K. Aytmuratova
Urkhiya K. Aytmuratova
FTFiruza Tursunkhodzhaeva
Firuza Tursunkhodzhaeva
Background: Epilepsy is a chronic, non-communicable brain disorder characterized by recurrent seizures. Some derivatives of 1,2,3,4-tetrahydroisoquinolines have demonstrated anticonvulsant effects. This study aims to investigate the effects of 33 derivatives of 1-aryl-1,2,3,4-tetrahydroisoquinoline on seizures induced by nicotine and strychnine. Methods: The anticonvulsant effects of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives were evaluated in white male mice. Convulsant agents were administered subcutaneously at doses of 10.0 mg/kg for nicotine and 1.5 mg/kg for strychnine, 60 min after the oral administration of the test compounds at doses ranging from 0.1 to 10 mg/kg. The onset time, duration of tremors and seizures, and survival rate of the animals were recorded. The docking studies were conducted for 32 tested compounds targeting the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor (PDB ID: 1FTL). Furthermore, a predictive ADMET study was conducted to evaluate the pharmacokinetic and toxicity profiles of the compounds. Results: Compounds 20 and 25 exhibited the highest activity against strychnine-induced seizures. When evaluating the effects of 1-aryl-1,2,3,4-tetrahydroisoquinolines and reference drugs on the tremorogenic and convulsive actions of nicotine at doses of 0.1–5 mg/kg, compounds 3, 6, 8, 14, 16, 25, 27, 29, 30, 31, and 34 demonstrated comparable activity to the reference drugs. The docking results targeting AMPA (PDB ID: 1FTL) revealed comparable binding interactions for most of the compounds, with a (−)C-Docker interaction energy range of 33.82–45.41 Kcal/mol, compared to that of the ligand (41.60 Kcal/mol). The structural requirements of the studied scaffold were analyzed to identify the essential pharmacophoric features for anticonvulsant activity. Furthermore, a predictive ADMET study was conducted to evaluate the pharmacokinetic and toxicity profiles of the compounds. Conclusions: Certain derivatives of 1,2,3,4-tetrahydroisoquinolines may serve as potential anticonvulsant agents for epilepsy.

4 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
AAAzizbek A. Azamatov
Azizbek A. Azamatov
FTFiruza Tursunkhodzhaeva
Firuza Tursunkhodzhaeva
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
ZBZufar Boboev
Zufar Boboev
KKKuvonchbek Fakhriddin ugli Kuchimov
Kuvonchbek Fakhriddin ugli Kuchimov
UGUlugbek G. Gayibov
Ulugbek G. Gayibov
Non-steroidal anti-inflammatory drugs (NSAIDs) are used globally for their pain-relieving and fever-reducing properties. However, excessive intake of NSAIDs can have harmful effects on multiple body systems, including the cardiovascular, gastrointestinal, hepatic, renal, and nervous systems. The anti-inflammatory activity of 34 derivatives of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline was investigated in vivo. A relationship between the activity of the compounds and the nature of their substituents, as well as their positional and mutual arrangement in the C ring (1-Ar-), was established. In silico modeling of these 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives’ interaction with the COX-2 (PDB ID: 1PXX) active site revealed that the nitro-derivatives exhibited the highest stability owing to their superior capacity for electrostatic and hydrogen bond formation compared to brominated compounds. These data on the effects of the substituents –NH2, –OH, and –OCH3 in ring C (1-Ar-) of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines on anti-inflammatory activity promote the search for new, highly effective derivatives within this series.

17 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAzizbek A. Azamatov
Azizbek A. Azamatov
FTFiruza Tursunkhodzhaeva
Firuza Tursunkhodzhaeva
SZSherzod Niyatqobilovich Zhurakulov
Sherzod Niyatqobilovich Zhurakulov
ZBZufar Boboev
Zufar Boboev
KKKuvonchbek Fakhriddin ugli Kuchimov
Kuvonchbek Fakhriddin ugli Kuchimov
VVValentina I. Vinogradova
Valentina I. Vinogradova
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used around the world for their pain-relieving and fever-reducing properties. However, excessive intake of NSAIDs can lead to harmful effects on multiple body systems, including the cardiovascular, gastrointestinal, hepatic, renal, and nervous systems. The anti-inflammatory activity of 34 derivatives of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline was investigated in vivo. A relationship between the activity of the compounds and the nature of the substituents, as well as their positional and mutual arrangement in the C ring (1-Ar-), was established. In silico modelling of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives interaction with COX-2 (PDB ID: 1PXX) active site indicated that the nitro-derivatives exhibited the highest stability owing to their superior capacity for electrostatic and hydrogen bond formation compare to brominated compounds. The presented data on the effect of substituents –NH₂, –OH, and –OCH₃ in ring C (1-Ar-) of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines on anti-inflammatory activity further stimulate the search for new highly effective derivatives within this series.